Public Company News
Zoomlion Launches Operations of New Factory in Europe Further Driving Localized Manufacturing
MANTOVA, Italy, June 8, 2021 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion"; 1157.HK) has officially launched operations of its new factory inEurope situated in the northern Italian town of Mantova. Now fully operational, the factory will further advance and im...
2021-06-08 17:02
20305
GWM's Globalization Strategy is accelerated on 2nd Anniversary of Tula Factory in Russia
BAODING, China, June 8, 2021 /PRNewswire/ -- June 5 witnessed the second anniversary of the operation of GWM's Tula factory inRussia. Since the first batch of HAVAL F7, HAVAL F7x, HAVAL H9 and other models got mass-produced, HAVAL-branded automobiles have ranked high in sales volume for many year...
2021-06-08 16:23
21015
AVerMedia launches Live Streamer NEXUS and MIC 330, a content creator control center/6-track audio mixer and a dynamic XLR microphone
TAIPEI, June 8, 2021 /PRNewswire/ -- AVerMedia Technologies, Inc., a leader in
digital audio and video, today announced it has launched the Live StreamerNEXUS
2021-06-08 16:00
3361
Inspiring Women's Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System
SHENZHEN, China, June 8, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global
leading developer and provider of medical devices and solutions, has introduced
theNuewa I9
2021-06-08 15:37
10190
Ying Hai Announces Possible Acquisition of a Zhuhai Travel Company
HONG KONG, June 8, 2021 /PRNewswire/ -- Ying Hai Group Holdings Company Limited ("the Company" or "Ying Hai Group", together with its subsidiaries, the "Group", HKSE stock code: 8668) is pleased to announce that, the Group will acquire Zhuhai Huanya International Tourism Co., Ltd. ("Target Comp...
2021-06-08 11:35
15848
Pearl Abyss Releases BUGATTI Collaboration for Black Desert
SEOUL, South Korea, June 8, 2021 /PRNewswire/ -- Pearl Abyss today announced a
collaboration with BUGATTI. The prestigious French brand will appear across the
world ofBlack Desert across all platforms. Adventurers can now enjoy this
collaboration through special quests and branded items.
2021-06-08 10:47
3156
Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress
SAN FRANCISCO and SUZHOU, China, June 8, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-06-08 08:00
5523
Live from ASCO 2021 | Ascentage Pharma Delivers Oral Presentation Featuring Updated Data Demonstrating Promising Efficacy and Safety of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Patients with Relapsed or Refractory CLL/SLL
SUZHOU, China, and ROCKVILLE, MD, June 8, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today released updated results from the first...
2021-06-08 07:30
5508
Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs
SUZHOU, China, and ROCKVILLE, Md., June 8, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today presented in an oral presentation at t...
2021-06-08 07:21
12856
ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in the United States and Puerto Rico
RARITAN, N.J., June 7, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care ...
2021-06-07 21:00
6506
Elekta's new strategy to focus on growth and access to radiation therapy
STOCKHOLM, June 7, 2021 /PRNewswire/ -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO,Gustaf Salford, and members from his executive management team introduced the company's mid-term strategy, called Access 2025. The strategy reflects the work the company will continue to do to pursue the visi...
2021-06-07 20:44
14164
RedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study
The global Phase 2/3 study of orally-administered opaganib for the treatment of severe COVID-19 enrolled a total of 475 patients, more than the planned 464 Opaganib is uniquely positioned as a leading novel, dual-action, investigational COVID-19 oral pill Blinded blended mortality rates encourag...
2021-06-07 19:00
5395
Clarivate Forecasts Nearly 70% of North American, European and Asia Pacific Adult Populations Will Be Vaccinated for COVID-19 by September 2021
New report analyzes how the emergence and increased availability of vaccines will impact the recovery of healthcare markets across the globe LONDON, June 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of inn...
2021-06-07 16:15
6664
Elekta and Philips deepen strategic partnership in precise and individualized oncology care
STOCKHOLM and AMSTERDAM, June 7, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) and Royal Philips (NYSE: PHG, AEX: PHIA) today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions. The extended collab...
2021-06-07 16:02
6700
WeChat Pay HK and Visa Collaborate to Support Disbursement of Hong Kong SAR Government's Consumption Voucher Scheme
* Collaboration aims to boost economic recovery and digital transformation of small and medium-sized businesses inHong Kong * WeChat Pay HK to waive service fee transactions for "WeChat Pay HK Checkout" merchants during the scheme period; Visa to invest in driving consumptionvoucher usage HON...
2021-06-07 15:30
17010
Aker Solutions Extends Relationship with Cognizant to Modernize its IT Systems and Help Speed Transition to Renewable Energy
By transforming and modernizing its IT Systems, Aker Solutions can offer more flexibility and faster time-to-market for its oil and gas customers TEANECK, N.J., June 7, 2021 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) announced today that it has extended its relationship with global engineering com...
2021-06-07 15:30
9060
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Plus Paclitaxel/Cisplatin for the First-line Treatment of ESCC at ASCO 2021
SUZHOU, China, June 7, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced data from Phase 2 clinical study (KN046-204) of KN046(PD-L1/CTLA-4 bispecific antibody) plus paclitaxel/cisplatin for the first-line treatment of unresectable locally advanced, recurrent or metastatic e...
2021-06-07 10:11
7209
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Combined with Chemotherapy for the Treatment of Advanced NSCLC at ASCO 2021
* KN046 combined with platinum doublet chemotherapy is tolerated and has shown promising clinical benefit as IL treatment for stage IV NSCLC. * OS rate at 12 months and 15 months were both 74.9%; Similar survival was observed in patients with PD-L1≥1% and PD-L1<1%; * the median progression-f...
2021-06-07 10:10
6663
Poster Highlighting Clinical Data of KN046 Plus Nab-Paclitaxel/Gemcitabine as First-Line Treatment for Pancreatic Cancer Is Presented at ASCO 2021
* As of January 15, 2021, 9 patients were included in the efficacy analysis and 17 patients in the safety analysis. ORR was 55.6%, and DCR was 88.9%. * The updated results from this Phase II study will be presented at an upcoming medical meeting. A phase III clinical study of KN046 in combinat...
2021-06-07 09:53
6720
CSOP Asset Management Ltd. Chooses SS&C to Support Operations
WINDSOR, Conn., June 7, 2021 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced thatHong Kong's CSOP Asset Management Ltd. has selected Eze Investment Suite for order management and portfolio accounting. Eze Investment Suite provides the flexibility CSOP required for ...
2021-06-07 09:00
11244
Week's Top Stories
Most Reposted
UFO SIM Launches in Australia, The Ultimate Travel eSIM Starting at Just AU$2/GB
[Picked up by 310 media titles]
2026-04-01 11:03
Sustainable Tourism Impact Fund Expands Investments Across Southeast Asia
[Picked up by 309 media titles]
2026-04-03 11:30
Surfin Meta Digital Technology signs MOU with the Philippine Social Security System to explore digital financial service enhancements
[Picked up by 307 media titles]
2026-04-01 09:00
Visa cements global K-pop connection as Worldwide Tour Sponsor for "BTS WORLD TOUR 'ARIRANG'"
[Picked up by 305 media titles]
2026-04-06 10:00
UTP Advances Across Key Disciplines in QS World University Rankings By Subject 2026 - Petroleum Engineering Among World's Top 10
[Picked up by 297 media titles]
2026-04-06 16:46
Most Read
NYSE Content Update: Versigent To Ring Opening Bell As its Shares Debut for Trade
2026-04-01 22:44
5948
LightInTheBox Files 2025 Annual Report on Form 20-F
2026-04-02 20:00
5546
